ES2123133T3 - Derivados esteroidianos, composiciones farmaceuticas que contienen estos derivados esteroidianos y utilizacion de estos ultimos como antibioticos o desinfectantes. - Google Patents

Derivados esteroidianos, composiciones farmaceuticas que contienen estos derivados esteroidianos y utilizacion de estos ultimos como antibioticos o desinfectantes.

Info

Publication number
ES2123133T3
ES2123133T3 ES94911470T ES94911470T ES2123133T3 ES 2123133 T3 ES2123133 T3 ES 2123133T3 ES 94911470 T ES94911470 T ES 94911470T ES 94911470 T ES94911470 T ES 94911470T ES 2123133 T3 ES2123133 T3 ES 2123133T3
Authority
ES
Spain
Prior art keywords
steroidial
derivatives
pct
alpha
side chain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94911470T
Other languages
English (en)
Inventor
Leah L Frye
Michael A Zasloff
William A Kinney
Robert M Moriarty
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Magainin Pharmaceuticals Inc
Original Assignee
Magainin Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Magainin Pharmaceuticals Inc filed Critical Magainin Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2123133T3 publication Critical patent/ES2123133T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0088—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing unsubstituted amino radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C07J9/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

COMPUESTOS QUE TIENE UN AMPLIA GAMA DE ACTIVIDAD ANTIMICROBIANA TIENEN GENERALMENTE UNA ESTRUCTURA QUE COMPRENDE UN NUCLEO ESTEROIDE CON UNA CADENA LATERAL,PREFERENTEMENTE POLIAMIDA CATIONICA Y UNA CADENA LATERAL ANIONICA (Y).LA INVENCION SE REFIERE TAMBIEN A COMPUESTOS DE FORMULA (III) PREFERENTEMENTE DONDE EL NUCLEO DE ANILLO DE ESTEROIDE ESTA SATURADO, LOS SUSTITUYENTES DE ANILLO DE ESTEROIDE Z{SUB,5} ES {AL}-H; UN Z{SUB,7} ES {BE}H Y EL OTRO ES {AL}-H O {AL}OH, AMBOS SUSTITUYENTES Z{SUB,12} SON HIDROGENO; X'' ES UNA CADENA LATERAL POLIAMINA DE LA FORMULA -NH-({CH{SUB,2})}{SUB,P}-NH{(CH{SUB,2})}{SUB,Q}-N{(R{SUP,II})}{(R{SUP,III})} DONDE P Y Q SON CADA UNO INDEPENDIENTEMENTE 3 O 4,Y R{SUP,II} Y R{SUP,III} SON CADA UNO INDEPENDIENTEMENTE HIDROGENO O METILO; R'' ES METILO; Y Y'' ES ALKILO C{SUB,1-10} SUSTITUIDO CON UN GRUPO TAL COMO CO{SUB,2}H O -SO{SUB,3}H.
ES94911470T 1993-03-10 1994-03-10 Derivados esteroidianos, composiciones farmaceuticas que contienen estos derivados esteroidianos y utilizacion de estos ultimos como antibioticos o desinfectantes. Expired - Lifetime ES2123133T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2901893A 1993-03-10 1993-03-10

Publications (1)

Publication Number Publication Date
ES2123133T3 true ES2123133T3 (es) 1999-01-01

Family

ID=21846774

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94911470T Expired - Lifetime ES2123133T3 (es) 1993-03-10 1994-03-10 Derivados esteroidianos, composiciones farmaceuticas que contienen estos derivados esteroidianos y utilizacion de estos ultimos como antibioticos o desinfectantes.

Country Status (9)

Country Link
US (3) US5637691A (es)
EP (1) EP0688333B1 (es)
JP (1) JP3546886B2 (es)
AT (1) ATE169930T1 (es)
CA (1) CA2157594A1 (es)
DE (1) DE69412596T2 (es)
DK (1) DK0688333T3 (es)
ES (1) ES2123133T3 (es)
WO (1) WO1994020520A1 (es)

Families Citing this family (83)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2123133T3 (es) * 1993-03-10 1999-01-01 Magainin Pharma Derivados esteroidianos, composiciones farmaceuticas que contienen estos derivados esteroidianos y utilizacion de estos ultimos como antibioticos o desinfectantes.
US5856535A (en) * 1994-08-18 1999-01-05 Magainin Pharmaceuticals, Inc. Aminosterol ester compounds
US5840740A (en) * 1995-06-07 1998-11-24 Magainin Pharmaceuticals Inc. Aminosterol compounds and a method of treating infection using the aminosterol compounds
US6071890A (en) * 1994-12-09 2000-06-06 Genzyme Corporation Organ-specific targeting of cationic amphiphile/DNA complexes for gene therapy
US5840710A (en) * 1994-12-09 1998-11-24 Genzyme Corporation Cationic amphiphiles containing ester or ether-linked lipophilic groups for intracellular delivery of therapeutic molecules
US5747471A (en) * 1994-12-09 1998-05-05 Genzyme Corporation Cationic amphiphiles containing steroid lipophilic groups for intracellular delivery of therapeutic molecules
US5910487A (en) * 1994-12-09 1999-06-08 Genzyme Corporation Cationic amphiphiles and plasmids for intracellular delivery of therapeutic molecules
US6331524B1 (en) 1994-12-09 2001-12-18 Genzyme Corporation Organ-specific targeting of cationic amphiphile / DNA complexes for gene therapy
US5719131A (en) * 1994-12-09 1998-02-17 Genzyme Corporation Cationic amphiphiles containing dialkylamine lipophilic groups for intracellular delivery of therapeutic molecules
US5767099A (en) * 1994-12-09 1998-06-16 Genzyme Corporation Cationic amphiphiles containing amino acid or dervatized amino acid groups for intracellular delivery of therapeutic molecules
US5948767A (en) * 1994-12-09 1999-09-07 Genzyme Corporation Cationic amphiphile/DNA complexes
US6383814B1 (en) 1994-12-09 2002-05-07 Genzyme Corporation Cationic amphiphiles for intracellular delivery of therapeutic molecules
US5650096A (en) * 1994-12-09 1997-07-22 Genzyme Corporation Cationic amphiphiles for intracellular delivery of therapeutic molecules
EP0832094B1 (en) * 1995-06-07 2004-02-11 Genaera Corporation Aminosterol compounds useful as inhibitors of the sodium/proton exchanger (nhe), pharmaceutical methods and compositions employing such inhibitors, and processes for evaluating the nhe-inhibitory efficacy of compounds
US5795885A (en) * 1995-06-07 1998-08-18 Magainin Pharmaceuticals Inc. Method of inhibiting profileration of cells by administering an aminosterol compound
US5840936A (en) * 1995-06-07 1998-11-24 Magainin Pharmaceuticals Inc. Aminosterol compounds useful as inhibitors of the sodium/proton exchanger (NHE)
US5994336A (en) * 1995-06-07 1999-11-30 Magainin Pharmaceuticals Inc. Method of inhibiting proliferation of cells by administering an aminosterol compound
US6143738A (en) * 1995-06-07 2000-11-07 Magainin Pharmaceuticals, Inc. Therapeutic uses for an aminosterol compound
US5847172A (en) * 1995-06-07 1998-12-08 Magainin Pharmaceuticals Inc. Certain aminosterol compounds and pharmaceutical compositions including these compounds
US5792635A (en) * 1995-06-07 1998-08-11 Magainin Pharmaceuticals, Inc. Method of inhibiting the sodium/proton exchanger NHE3 and method of inhibiting growth by administering squalamine
US5874597A (en) * 1995-06-07 1999-02-23 Magainin Pharmaceuticals, Inc. Certain aminosterol compounds and pharmaceutical compositions including these compounds
US5763430A (en) * 1995-06-07 1998-06-09 Magainin Pharmaceuticals Inc. Method of treating a viral infection by administering a steroid compound
FR2744453B1 (fr) * 1996-02-05 1998-07-10 Transgene Sa Composes lipopolyamines, compositions pharmaceutiques en comprenant, vecteurs de transfert d'acide nucleique et procede de preparation
PT910382E (pt) * 1996-04-26 2003-10-31 Genaera Corp Esqualamina em combinacao com outros agentes anti-cancro para o tratamento de tumores
US6596712B2 (en) 1996-04-26 2003-07-22 Genaera Corporation Treatment of carcinomas using squalamine in combination with other anti-cancer agents or modalities
US7410959B1 (en) 2000-07-13 2008-08-12 Genaera Corporation Therapeutic uses for aminosterol compounds
AU2911197A (en) * 1996-05-24 1998-01-05 Imperial College Of Science, Technology And Medicine Polycationic sterol derivatives as transfection agents
US5935936A (en) * 1996-06-03 1999-08-10 Genzyme Corporation Compositions comprising cationic amphiphiles and co-lipids for intracellular delivery of therapeutic molecules
US6262283B1 (en) 1996-12-06 2001-07-17 Magainin Pharmaceuticals Inc. Stereoselective synthesis of 24-hydroxylated compounds useful for the preparation of aminosterols, vitamin D analogs, and other compounds
US5925628A (en) * 1997-03-31 1999-07-20 Genzyme Corporation Cationic amphiphiles for intracellular delivery of therapeutic molecules
US5912239A (en) * 1997-04-04 1999-06-15 Genzyme Corporation Imidazole-containing cationic amphiphiles for intracellular delivery of therapeutic molecules
US5948925A (en) * 1997-05-06 1999-09-07 Genzyme Corporation Cationic amphiphiles containing linkers derived from neutral or positively charged amino acids
US5952516A (en) * 1997-05-08 1999-09-14 Genzyme Corporation Cationic amphiphiles containing multiplesteroid lipophilic groups
US5942634A (en) * 1997-05-09 1999-08-24 Genzyme Corporation Cationic amphiphiles for cell transfections
CA2322847C (en) * 1998-03-06 2008-05-13 Brigham Young University Steroid derived antibiotics
US6767904B2 (en) 1998-03-06 2004-07-27 Bringham Young University Steroid derived antibiotics
US6350738B1 (en) 1998-03-06 2002-02-26 Brigham Young University Steroid derived antibiotics
ES2347027T3 (es) 1998-05-22 2010-10-22 The Board Of Trustees Of The Leland Stanford Junior University Moleculas bifuncionales y terapias basadas en las mismas.
AU773038B2 (en) * 1998-08-12 2004-05-13 Genaera Corporation Aminosterol compounds and uses thereof
EP1119361A4 (en) * 1998-09-10 2006-10-04 Magainin Pharma TREATMENT OF CARCINOMA WITH SQUALAMINE IN COMBINATION WITH OTHER ANTI-TUMOR AGENTS
US6537554B1 (en) 1998-09-10 2003-03-25 Curagen Corporation Nucleotide sequences and amino acid sequences of secreted proteins involved in angiogenesis
CA2370821A1 (en) * 1999-05-01 2000-11-09 Genaera Corporation Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
AU2004201177B2 (en) * 1999-10-14 2006-03-30 Sasol Technology (Pty) Limited Handling of a Catalyst
EP1235849A2 (en) * 1999-12-09 2002-09-04 Genaera Corporation Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
DE60123939T2 (de) 2000-04-12 2007-05-31 Genaera Corp. Ein verfahren zur herstellung von 7.alpha.-hydroxy 3-aminosubstituierten sterol-verbindungen, ohne schutz der 7.alpha.-hydroxy-gruppe
DE60126597T2 (de) * 2000-04-28 2007-10-31 Inflazyme Pharmaceuticals, Ltd., Richmond 3-stickstoff-6,7-dioxygenierte steroid verbindungen und verwendungen davon
US20030181742A1 (en) * 2000-09-08 2003-09-25 Makoto Nakazawa Process for the preparation of pregnane derivatives
US20030104573A1 (en) * 2000-09-11 2003-06-05 Shimkets Richard A. Nucleotide sequences and amino acid sequences of secreted proteins involved in angiogenesis
US7855342B2 (en) * 2000-09-25 2010-12-21 Ibiden Co., Ltd. Semiconductor element, method of manufacturing semiconductor element, multi-layer printed circuit board, and method of manufacturing multi-layer printed circuit board
JP2004520372A (ja) * 2001-01-25 2004-07-08 ザ ユニバーシティ オブ ブリティッシュ コロンビア 抗血管形成性化合物及び細胞浸潤の阻害剤のアッセイ
CA2332138A1 (en) * 2001-01-25 2002-07-25 Michel Roberge Antiangiogenic compounds and an assay for inhibitors of cell invasion
MXPA03008085A (es) * 2001-03-21 2004-03-10 Leo Pharma As Derivados de acido fusidico poliaminados novedosos.
EP2147679B1 (en) 2001-07-25 2014-06-25 Raptor Pharmaceutical, Inc. Compositions for blood-brain barrier transport
US7557097B2 (en) * 2004-11-20 2009-07-07 Regents Of The University Of Minnesota Structural, behavioral characterization, and synthesis of attractants for migratory lamprey
JP2008539243A (ja) 2005-04-25 2008-11-13 ジェネーラ・コーポレーション スクアラミンジラクテートの多形塩形態および無定形塩形態
WO2006116718A2 (en) 2005-04-28 2006-11-02 Proteus Biomedical, Inc. Pharma-informatics system
US9062126B2 (en) 2005-09-16 2015-06-23 Raptor Pharmaceuticals Inc. Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof
CN100410270C (zh) * 2005-12-31 2008-08-13 中山大学 胆甾-5-烯-3β，19-二羟基-24-酮及衍生物的合成方法
CN100436474C (zh) * 2005-12-31 2008-11-26 中山大学 胆甾-3β，5α，6β，19-四羟基-24-酮及其衍生物的合成方法
CN101600429A (zh) * 2006-12-08 2009-12-09 哈多技术有限公司 治疗和预防传染性疾病的胆固醇胺
TWI433674B (zh) 2006-12-28 2014-04-11 Infinity Discovery Inc 環杷明（ｃｙｃｌｏｐａｍｉｎｅ）類似物類
CA2697744C (en) * 2007-09-06 2016-06-14 Genaera Corporation A method for treating diabetes
US8716479B2 (en) 2007-12-27 2014-05-06 Infinity Pharmaceuticals, Inc. Methods for stereoselective reduction
WO2009090063A1 (en) * 2008-01-16 2009-07-23 Jado Technologies Gmbh Steroid sapogenin, androstane and triterpenoid sapogenin derivatives for the treatment and prevention of infectious diseases
HUE026025T2 (en) 2008-05-09 2016-05-30 Merck Patent Gmbh A pharmaceutical composition comprising rimeporide for the treatment of diseases associated with beta cell dysfunction
JP5564517B2 (ja) 2009-02-20 2014-07-30 ティーオー − ビービービー ホールディング ベスローテン フェンノートシャップ グルタチオンをベースとする薬物送達システム
CN102458374A (zh) 2009-05-06 2012-05-16 实验室护肤股份有限公司 包含活性剂-磷酸钙颗粒复合物的皮肤递送组合物及其使用方法
CN102574791A (zh) 2009-08-05 2012-07-11 无限药品股份有限公司 环杷明类似物的酶促转氨基反应
US8729058B2 (en) * 2009-10-27 2014-05-20 Michael Zasloff Methods and compositions for treating and preventing viral infections
JP5147814B2 (ja) * 2009-11-12 2013-02-20 ブリガム・ヤング・ユニバーシティ ステロイド由来抗生物質
WO2011066260A2 (en) * 2009-11-25 2011-06-03 Michael Zasloff Formulations comprising aminosterols
WO2012037217A1 (en) 2010-09-14 2012-03-22 Infinity Pharmaceuticals, Inc. Transfer hydrogenation of cyclopamine analogs
US9056923B2 (en) 2010-12-10 2015-06-16 The Johns Hopkins University Mimetic peptides derived from collagen type IV and their use for treating angiogenesis- and lymphagiogenesis-dependent diseases
FR2981351A1 (fr) 2011-10-17 2013-04-19 Univ Nice Sophia Antipolis Derives aminosteroidiens anti-diabetiques
KR101963312B1 (ko) * 2012-04-20 2019-03-28 오에이치알 파마서티컬, 인코포레이티드 Ptp1b 연관 질병의 치료용 아미노스테로이드
US10040817B2 (en) 2013-10-03 2018-08-07 Enterin Laboratories, Inc. Methods and compositions for stimulation of the intestinal enteroendocrine system for treating diseases or conditions related to the same
AU2016271468B2 (en) 2015-06-04 2020-01-02 Sol-Gel Technologies Ltd. Topical formulations for delivery of hedgehog inhibitor compounds and use thereof
FR3055801B1 (fr) * 2016-09-15 2020-10-30 Virbac Derives esters de squalamine pour le traitement des infections
EP3678671A4 (en) 2017-09-08 2022-12-07 Enterin, Inc. METHODS OF TREATING SLEEP DISORDERS, SLEEP DISTURBANCES AND ASSOCIATED SYMPTOMS USING AMINOSTEROL COMPOSITIONS
CN108445236B (zh) * 2018-02-07 2021-04-20 深圳市新产业生物医学工程股份有限公司 甾体类衍生物和其保存液以及其应用
EP4007764A4 (en) * 2019-08-02 2023-08-09 Enterin, Inc. HUMAN ENT-03 AMINOSTEROL COMPOUNDS, RELATED COMPOSITIONS COMPRISING THEM, AND METHODS OF USE THEREOF
JP2022543244A (ja) * 2019-08-02 2022-10-11 エンターイン、 インコーポレイテッド ヒトスクアラミン誘導体、それを含む関連組成物、およびそれを用いた方法
EP4121434A4 (en) * 2020-03-19 2024-04-24 Enterin Inc CRYSTALLINE FORMS OF SQUALAMINE

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3016390A (en) * 1960-06-30 1962-01-09 Searle & Co N-(substituted alkyl) amino-5alpha-androstan-17beta-ols
US3370070A (en) * 1965-06-16 1968-02-20 Searle & Co [n-alkyl-17-(dialkylaminoalkyl)amino] androst-4-en-3-ones
GB1565351A (en) * 1975-06-02 1980-04-16 Theramex Steroid aminoethers
US4220598A (en) * 1977-11-14 1980-09-02 Abbott Laboratories Method and reagents for measuring the level of conjugated bile acids
US4550163A (en) * 1979-02-05 1985-10-29 Abbott Laboratories Ligand analog-irreversible enzyme inhibitor conjugates
US4372888A (en) * 1980-08-26 1983-02-08 The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services Nondenaturing zwitterionic detergents
JPS5842878B2 (ja) * 1981-12-02 1983-09-22 名糖産業株式会社 １２−オキソコラン酸トシルヒドラゾン化合物、その製法ならびに利用
DE3366932D1 (en) * 1982-07-29 1986-11-20 Lehner Ag New derivatives of biliary acids, process for the production thereof and pharmaceutical compositions containing the same
US5001116A (en) * 1982-12-20 1991-03-19 The Children's Medical Center Corporation Inhibition of angiogenesis
US4994443A (en) * 1982-12-20 1991-02-19 The Children's Medical Center Corporation Inhibition of angiogenesis
IT1221734B (it) * 1983-02-24 1990-07-12 Schiena Michele Giuseppe Di Ursodesossicolico solfato acido sale sodico
US4545938A (en) * 1983-11-02 1985-10-08 Beth Israel Medical Center Chemical synthesis
EP0243449A1 (en) * 1985-10-18 1987-11-04 The Upjohn Company Cyclic hydrocarbons with an aminoalkyl sidechain
US4771042A (en) * 1985-11-25 1988-09-13 The Upjohn Company Inhibition of angiogenesis involving the coadministration of steroids with heparin or heparin fragments
JPS62175497A (ja) * 1986-01-28 1987-08-01 Wakunaga Pharmaceut Co Ltd 胆汁酸誘導体およびその製造法
US5075464A (en) * 1987-04-22 1991-12-24 Merrell Dow Pharmaceuticals Inc. 17β-(cyclopropylamino)androstene derivatives
SE8702254D0 (sv) * 1987-05-29 1987-05-29 Kabivitrum Ab Novel heparin derivatives
US5135919A (en) * 1988-01-19 1992-08-04 Children's Medical Center Corporation Method and a pharmaceutical composition for the inhibition of angiogenesis
IT1229570B (it) * 1989-04-17 1991-09-04 Giuliani Spa Derivati fluorurati di acidi biliari, loro preparazione e composizioni farmaceutiche che li contengono.
IT1229569B (it) * 1989-04-17 1991-09-04 Giuliani Spa Derivati di acidi biliari, loro preparazione e composizioni farmaceutiche che li contengono.
JPH07116215B2 (ja) * 1989-04-19 1995-12-13 エスエス製薬株式会社 新規なステロイド化合物
PT93847A (pt) * 1989-04-24 1990-11-20 Harvard College Processo para a preparacao de oligossacaridos de baixo peso molecular derivados de heparina ou de sulfato de heparano despolimerizados e de composicoes farmaceuticas que os contem
US4966897A (en) * 1989-08-15 1990-10-30 Merrell Dow Pharmaceuticals Inc. 4-substituted 17β-(cyclopropyloxy)androst-5-en-3β-ol and related compounds useful as C17-20 lyase inhibitors
US5004737A (en) * 1989-09-22 1991-04-02 Pacific Chemical Co., Ltd. Quaternary ammonium-substituted sterol derivatives
EP0466315A3 (en) * 1990-05-30 1992-07-01 Larrian Gillespie Compositions containing xylan sulphates for affecting growth factor function and for inhibiting fibroblast proliferation
DK0533703T3 (da) * 1990-06-11 2000-08-14 Alcon Lab Inc Anvendelse af steroider til hæmning af angiogenese
IL100240A (en) * 1990-12-06 1995-10-31 Hoechst Ag History of bile acids, the process for their preparation and pharmaceutical preparations containing them
US5192756A (en) * 1992-03-18 1993-03-09 The Children's Hospital Of Pennsylvania Aminosterol antibiotic
WO1993025197A1 (en) * 1992-06-12 1993-12-23 Affymax Technologies N.V. Compositions and methods for enhanced drug delivery
AU6392894A (en) * 1993-02-26 1994-09-14 Magainin Pharmaceuticals, Inc. Chemical synthesis of squalamine
ES2123133T3 (es) * 1993-03-10 1999-01-01 Magainin Pharma Derivados esteroidianos, composiciones farmaceuticas que contienen estos derivados esteroidianos y utilizacion de estos ultimos como antibioticos o desinfectantes.

Also Published As

Publication number Publication date
DK0688333T3 (da) 1999-02-08
WO1994020520A1 (en) 1994-09-15
US5721226A (en) 1998-02-24
JPH08507527A (ja) 1996-08-13
EP0688333A1 (en) 1995-12-27
AU692766B2 (en) 1998-06-18
DE69412596T2 (de) 1999-03-04
US5637691A (en) 1997-06-10
DE69412596D1 (de) 1998-09-24
ATE169930T1 (de) 1998-09-15
AU6397494A (en) 1994-09-26
CA2157594A1 (en) 1994-09-15
EP0688333B1 (en) 1998-08-19
US5733899A (en) 1998-03-31
JP3546886B2 (ja) 2004-07-28

Similar Documents

Publication Publication Date Title
ES2123133T3 (es) Derivados esteroidianos, composiciones farmaceuticas que contienen estos derivados esteroidianos y utilizacion de estos ultimos como antibioticos o desinfectantes.
ES2164110T3 (es) Usos farmaceuticos de derivados de esteroides.
MX9700584A (es) Agentes para combatir las pestes de la plantas.
ES2164657T3 (es) Derivados aza-biciclicos puenteados como antagonistas de la sustancia p.
AU5165393A (en) Substituted benzylaminoquinuclidines as substance p antagonists
DE68929307T2 (de) Guanidinderivate, ihre Herstellung und Insektizide
ES2150353A1 (es) Tienilazolilalcoxietanaminas, su preparacion y su aplicacion como medicamentos.
ES2104867T3 (es) Compuestos de polifluoroalquiltiopoli(etilimidazolio), procedimiento de preparacion y su utilizacion como agentes biocidas.
DE69609325T2 (de) Derivate des radicicols
AU2267495A (en) Benzamide derivatives as vasopressin antagonists
MY114174A (en) Insecticidal tetrahydrofuran-compound
DE69912472D1 (de) Biozidzusammensetzung und diese verwendendes sterilisationsverfahren
CA2252402A1 (en) Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
AU2028097A (en) Amino- and hydroxysubstituted triphenyl-s-triazines as stabilizers
MX9600816A (es) Nuevos derivados triciclicos, su preparacion, su aplicacion a la preparacion de la colquicina y de la tiocolquicina, opticamente activas o racemicas, y de compuestos analogos o derivados e intermedios.
ZA9429B (en) Pyrrolidine derivatives their preparation and medicaments containing them
ATE207460T1 (de) Benzocycloalken-verbindungen mit bindungsaffinität an den melatonin-rezeptor, ihre herstellung und verwendung
IL97105A0 (en) Indole derivatives,their preparation and pharmaceutical compositions containing them
ZA9480B (en) Pyrrolidine derivatives their preparation and medicaments containing them
PT625982E (pt) 4-oxo- e 4h-imidazo(5,1-c)(1,4)benzoxazinas uteis como agentes de ligacao ao receptor de benzodiazepina
EP0579129A3 (es)
ATE52501T1 (de) Cyclohexan-1,3-dionderivate, diese enthaltende zusammensetzungen, verfahren zu deren herstellung und deren verwendung als herbizide und pflanzenwachstumsregulatoren.
JO1674B1 (en) Benzimidazole is an alternative and method of preparation and use of a pharmacist
ATE126504T1 (de) 1-phenoxycarbonyl-2-pyrrolidon-derivate und nootrope wirkstoffe.
JO1672B1 (en) Dialoxy-pyridinyl-benzimidazole derivatives and a way to prepare and use it in a pharmacy

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 688333

Country of ref document: ES